244 related articles for article (PubMed ID: 31097095)
1. Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.
Kunimasa K; Nakamura H; Sakai K; Tamiya M; Kimura M; Inoue T; Nishino K; Kuhara H; Nakatsuka SI; Nishio K; Imamura F; Kumagai T
Lung Cancer; 2019 Jun; 132():59-64. PubMed ID: 31097095
[TBL] [Abstract][Full Text] [Related]
2. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
[TBL] [Abstract][Full Text] [Related]
3. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
[TBL] [Abstract][Full Text] [Related]
4. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
Crombé A; Alberti N; Villard N; Pilleul F; Buy X; Le Loarer F; Kind M
Eur Radiol; 2019 Sep; 29(9):4730-4741. PubMed ID: 30762113
[TBL] [Abstract][Full Text] [Related]
5. Cytopathological Features of
Takeda M; Tani Y; Saijo N; Shimizu S; Taniguchi Y; Otsuka K; Nakao K; Tamiya A; Okishio K; Atagi S; Ohbayashi C; Kasai T
Int J Surg Pathol; 2020 Feb; 28(1):109-114. PubMed ID: 31448657
[No Abstract] [Full Text] [Related]
6. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.
Kuwamoto S; Matsushita M; Takeda K; Tanaka N; Endo Y; Yamasaki A; Kohashi K; Oda Y; Horie Y
Hum Pathol; 2017 Dec; 70():92-97. PubMed ID: 28601660
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
[TBL] [Abstract][Full Text] [Related]
8. SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma.
Khanchel F; Hedhili R; Zenaidi H; Helal I; Yahmadi A; Ben Néji H; Ksontini F; Ben Brahim E; Jouini R; Chadli A
Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1155-1158. PubMed ID: 33866513
[TBL] [Abstract][Full Text] [Related]
9. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract][Full Text] [Related]
10. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
Matsushita M; Kuwamoto S
Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
[TBL] [Abstract][Full Text] [Related]
11. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract][Full Text] [Related]
12. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract][Full Text] [Related]
13. Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.
Shinno Y; Ohe Y;
Jpn J Clin Oncol; 2024 Mar; 54(3):265-270. PubMed ID: 38117955
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications.
Leckey BD; Selim MA; Al-Rohil RN
J Cutan Pathol; 2020 Jun; 47(6):561-565. PubMed ID: 31995235
[TBL] [Abstract][Full Text] [Related]
15. Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: A case report.
Takada K; Sugita S; Murase K; Kikuchi T; Oomori G; Ito R; Hayasaka N; Miyanishi K; Iyama S; Ikeda H; Kobune M; Emori M; Kato J; Hasegawa T
Thorac Cancer; 2019 Dec; 10(12):2312-2315. PubMed ID: 31617320
[TBL] [Abstract][Full Text] [Related]
16. Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
PeerJ; 2024; 12():e16923. PubMed ID: 38374950
[TBL] [Abstract][Full Text] [Related]
17. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.
Le Loarer F; Watson S; Pierron G; de Montpreville VT; Ballet S; Firmin N; Auguste A; Pissaloux D; Boyault S; Paindavoine S; Dechelotte PJ; Besse B; Vignaud JM; Brevet M; Fadel E; Richer W; Treilleux I; Masliah-Planchon J; Devouassoux-Shisheboran M; Zalcman G; Allory Y; Bourdeaut F; Thivolet-Bejui F; Ranchere-Vince D; Girard N; Lantuejoul S; Galateau-Sallé F; Coindre JM; Leary A; Delattre O; Blay JY; Tirode F
Nat Genet; 2015 Oct; 47(10):1200-5. PubMed ID: 26343384
[TBL] [Abstract][Full Text] [Related]
18. A Subset of Thoracic SMARCA4-Deficient Undifferentiated Tumors Express GATA3.
Coconubo DM; Wangsiricharoen S; Pettus JR; Linos K; Pinto A; Wang WL; Kerr DA; Cloutier JM
Int J Surg Pathol; 2024 Jun; 32(4):684-691. PubMed ID: 37461275
[TBL] [Abstract][Full Text] [Related]
19.
Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
[No Abstract] [Full Text] [Related]
20. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
Kawachi H; Kunimasa K; Kukita Y; Nakamura H; Honma K; Kawamura T; Inoue T; Tamiya M; Kuhara H; Nishino K; Mizote Y; Akazawa T; Tahara H; Kumagai T
Immunotherapy; 2021 Jul; 13(10):799-806. PubMed ID: 34030451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]